ArticleClinical medicine insights. Endocrinology and diabetes2012

Linagliptin-a novel dipeptidyl peptidase inhibitor for type 2 diabetes therapy.

Baptist GallwitzPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.